Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine

By Straubinger R.K.   Dharma Rao T.   Davidson E.   Summers B.A.   Jacobson R.H.   Frey A.B.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 181-193

Elsevier

Access to resources Recommend Favorite

Evaluation of Venezuelan Equine Encephalitis (VEE) replicon-based Outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease

By Gipson C.L.   Davis N.L.   Johnston R.E.   de Silva A.M.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3875-3884

Elsevier

Access to resources Recommend Favorite

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi

By Golde W.T.   Burkot T.R.   Piesman J.   Dolan M.C.   Capiau C.   Hauser P.   Dequesne G.   Lobet Y.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 435-441

Elsevier

Access to resources Recommend Favorite

The Seventh International Congress on Lyme Borreliosis: progress on the development of Lyme disease vaccines

By Edelman R.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 463-464

Elsevier

Access to resources Recommend Favorite

Knowledge of Cardiovascular Disease Prevention: An Analysis from Two New England Communities

By Gans K.M.   Assmann S.F.   Sallar A.   Lasater T.M.  

Preventive Medicine, Vol. 29, Iss. 4, 1999-10 ,pp. : 229-237

Academic Press

Access to resources Recommend Favorite